familymednews.com
PARIS — France’s beauty export sales rose 9 percent to 15.7 billion euros in 2019 versus 2018, according to the country’s Fédération des Entreprises de la Beauté, or FEBEA, which cited numbers from the French customs office. That growth allowed the country to boast 23 percent market share worldwide last year. Source: Read Full Article
Continue reading »
The World Health Organization says the number of measles cases in Europe jumped sharply during the first six months of 2018 and at least 37 people have died. The U.N. agency’s European office said Monday more than 41,000 measles cases were reported in the region during the first half of the year—more than in all 12-month periods so far this […]
Continue reading »
“This is a virus transmitted by mosquitoes that circulates between birds. It can attack the nervous system of certain birds, such as blackbirds, and cause significant mortality. It was first observed in southern Africa, in Swaziland, in 1959,” says Serafin Gutierrez, a virology researcher with CIRAD”S ASTRE research unit. The virus, called Usutu, belongs to the genus Flavivirus, which includes […]
Continue reading »
HCV-related liver transplantation rates in Europe have declined dramatically since the availability of direct-acting antiviral (DAA) drugs and survival rates after transplantation have reached an all-time high. A study presented today at The International Liver Congress 2018 in Paris, France, has found that the percentage of liver transplants performed as a result of hepatitis C virus (HCV) infection has more […]
Continue reading »
Hepatitis A viruses (HAVs) circulating in an ongoing outbreak among men who have sex with men (MSM) in the Lombardy region of Italy are predominantly attributable to strains linked to two other recent outbreaks in Europe, according to a study presented today at The International Liver Congress 2018 in Paris, France. The study found that earlier cases in the Lombardy […]
Continue reading »
Experts from the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) regret the recent decision by the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) to reject the marketing application for abaloparatide, a potential new treatment option for postmenopausal women at high risk of […]
Continue reading »